These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 27554197)

  • 21. Cognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis.
    Hutton P; Taylor PJ
    Psychol Med; 2014 Feb; 44(3):449-68. PubMed ID: 23521867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised controlled trial of a digitally assisted low intensity intervention to promote personal recovery in persisting psychosis: SMART-Therapy study protocol.
    Thomas N; Farhall J; Foley F; Rossell SL; Castle D; Ladd E; Meyer D; Mihalopoulos C; Leitan N; Nunan C; Frankish R; Smark T; Farnan S; McLeod B; Sterling L; Murray G; Fossey E; Brophy L; Kyrios M
    BMC Psychiatry; 2016 Sep; 16(1):312. PubMed ID: 27604363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a group and family-based cognitive behavioural therapy program for youth at risk for psychosis.
    Landa Y; Mueser KT; Wyka KE; Shreck E; Jespersen R; Jacobs MA; Griffin KW; van der Gaag M; Reyna VF; Beck AT; Silbersweig DA; Walkup JT
    Early Interv Psychiatry; 2016 Dec; 10(6):511-521. PubMed ID: 25585830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten-year audit of clients presenting to a specialised service for young people experiencing or at increased risk for psychosis.
    Conrad AM; Lewin TJ; Sly KA; Schall U; Halpin SA; Hunter M; Carr VJ
    BMC Psychiatry; 2014 Nov; 14():318. PubMed ID: 25403891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of psychological interventions in young individuals at ultra-high risk for psychosis: A naturalistic study.
    Janssen H; Maat A; Slot MIE; Scheepers F
    Early Interv Psychiatry; 2021 Aug; 15(4):1019-1027. PubMed ID: 32945145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocol.
    Thomas N; Shawyer F; Castle DJ; Copolov D; Hayes SC; Farhall J
    BMC Psychiatry; 2014 Jul; 14():198. PubMed ID: 25015368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study.
    Fusar-Poli P; Frascarelli M; Valmaggia L; Byrne M; Stahl D; Rocchetti M; Codjoe L; Weinberg L; Tognin S; Xenaki L; McGuire P
    Psychol Med; 2015 Apr; 45(6):1327-39. PubMed ID: 25335776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive--behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial.
    Garety PA; Fowler DG; Freeman D; Bebbington P; Dunn G; Kuipers E
    Br J Psychiatry; 2008 Jun; 192(6):412-23. PubMed ID: 18515890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms.
    Jackson C; Trower P; Reid I; Smith J; Hall M; Townend M; Barton K; Jones J; Ross K; Russell R; Newton E; Dunn G; Birchwood M
    Behav Res Ther; 2009 Jun; 47(6):454-62. PubMed ID: 19361782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics.
    Phillips LJ; Nelson B; Yuen HP; Francey SM; Simmons M; Stanford C; Ross M; Kelly D; Baker K; Conus P; Amminger P; Trumpler F; Yun Y; Lim M; McNab C; Yung AR; McGorry PD
    Aust N Z J Psychiatry; 2009 Sep; 43(9):818-29. PubMed ID: 19670055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform Study (Improving Social Recovery in Early Psychosis).
    Fowler D; Hodgekins J; Painter M; Reilly T; Crane C; Macmillan I; Mugford M; Croudace T; Jones PB
    Psychol Med; 2009 Oct; 39(10):1627-36. PubMed ID: 19335932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial.
    Enander J; Andersson E; Mataix-Cols D; Lichtenstein L; Alström K; Andersson G; Ljótsson B; Rück C
    BMJ; 2016 Feb; 352():i241. PubMed ID: 26837684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A preliminary exploration of predictors of outcome and cognitive mechanisms of change in cognitive behaviour therapy for psychosis in people not taking antipsychotic medication.
    Morrison AP; Turkington D; Wardle M; Spencer H; Barratt S; Dudley R; Brabban A; Hutton P
    Behav Res Ther; 2012 Feb; 50(2):163-7. PubMed ID: 22209267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive therapy for internalised stigma in people experiencing psychosis: A pilot randomised controlled trial.
    Morrison AP; Burke E; Murphy E; Pyle M; Bowe S; Varese F; Dunn G; Chapman N; Hutton P; Welford M; Wood LJ
    Psychiatry Res; 2016 Jun; 240():96-102. PubMed ID: 27092862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges of assessment and treatment of ultra high risk for psychosis in an adolescent.
    Boričević Maršanić V; Jukić J; Flander M
    Psychiatr Danub; 2018 Jun; 30(Suppl 4):166-168. PubMed ID: 29864753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychological interventions for people with psychotic experiences: A systematic review and meta-analysis of controlled and uncontrolled effectiveness and economic studies.
    Soneson E; Russo D; Stochl J; Heslin M; Galante J; Knight C; Grey N; Hodgekins J; French P; Fowler D; Lafortune L; Byford S; Jones PB; Perez J
    Aust N Z J Psychiatry; 2020 Jul; 54(7):673-695. PubMed ID: 32462893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of age on outcome of psychological treatments in first-episode psychosis.
    Haddock G; Lewis S; Bentall R; Dunn G; Drake R; Tarrier N
    Br J Psychiatry; 2006 Mar; 188():250-4. PubMed ID: 16507967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis.
    Hartmann JA; McGorry PD; Schmidt SJ; Amminger GP; Yuen HP; Markulev C; Berger GE; Chen EYH; de Haan L; Hickie IB; Lavoie S; McHugh MJ; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma SK; Yung AR; Nelson B
    Psychother Psychosom; 2017; 86(5):292-299. PubMed ID: 28903120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
    Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
    Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.